agomab
The Safety Physician strengthens Drug Safety and Pharmacovigilance capabilities for a small-molecule portfolio, guiding programs from early development through proof of concept. This role involves overseeing safety data review, signal management, and benefit-risk evaluations to shape strategies for organ-restricted therapies. The position offers initial individual contributor responsibilities with potential for broader leadership as the function grows.
Agomab Therapeutics (Nasdaq: AGMB) is a clinical-stage biopharmaceutical company focused on fibro-inflammation, developing growth factor-modulating therapies to treat fibrotic diseases. The company's pipeline includes Ontunisertib (AGMB-129), AGMB-447, and AGMB-101, with active clinical programs targeting conditions such as fibrostenosing Crohn's disease and idiopathic pulmonary fibrosis. Headquartered in Antwerp, Belgium, Agomab translates deep expertise in growth factor biology into disease-modifying treatments aimed at halting or reversing fibrosis and restoring organ function.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for agomab.
agomab didn’t post a salary, so this is our estimate from similar listings.
Director, Drug Safety & Pharmacovigilance - Safety Scientist
Travere Therapeutics
Director, Drug Safety Physician
Jobgether
Associate Medical Safety Director- Sponsor Dedicated
lifelancer
Director, Drug Safety Physician
Spyre Therapeutics
Global Safety Officer, I&I
sanofi us
Lead Medical Safety Physician
Corcept Therapeutics